CD274 and metastatic neoplasm: Metastatic disease at the time of index date was associated with increased risk of death, whereas age ≥ 60 years, platinum-based therapy, and anatomic subsite of larynx were associated with a lower risk of death regardless of the PD-L1 cutoff used (Fig. 3; Table 4).